Footer - Free News - PharmProm.Net - Pharmaceutical Industry Information Portal

Type here...

News
Insights
Innovation
Events
Companies
Glossary

Instagram

Twitter

About us
GMP Database
Services
Promotion
Contact
? RU

Pharmaceutical Industry News & Insights

About us
GMP Database
Services
Promotion
Contact
? RU

type here...

Flipboard

Tumblr

News
- All EAEU Market Education Global Markets Manufacturing
  
  News
  Russian-Chinese Blood Plasma Production to be Localized in Nizhny Novgorod Region
  
  News
  Biotechnology Company BIOCAD Launches Its Own Biobank
  
  News
  GMP Registry Update: 16 New Certificates at the Turn of March and April 2026
  
  News
  VGNKI Inspects Four Foreign Veterinary Drug Manufacturers Since Early 2026
Insights
- All Expert Opinion Partner Posts
  
  Insights
  Russian Pharmaceutical Market in 2025: Production Growth and Import Substitution Course
  
  Expert Opinion
  GMP Registry Update: 8 New Certificates by the End of February 2026
  
  Expert Opinion
  Vadim Kukava: The Pharmaceutical Industry Should Not Be Divided into “Theirs” and “Ours”
  
  Global Markets
  Top Ten Most Anticipated Drug Launches of 2026 That Will Reshape the Global Market
Innovation
- All AI in Pharma Approvals Drug Development Research
  
  News
  New Equilibrium: Analytical Review of the Clinical Trials Market in Russia for 2025
  
  Drug Development
  American Scientists Create an Implant That Autonomously Produces Drugs Inside the Body
  
  AI in Pharma
  AI and Billion-Dollar Investments: Eli Lilly Signs an Agreement with Insilico Medicine Worth Up to $2.75 Billion
  
  Research
  New Horizons in SMA Treatment: Promomed Launches Large-Scale Study Based on Risdiplam
Events
- All Reports Upcoming
  
  Upcoming
  PHARMPROM Portal Becomes a Media Partner of the International Pharmacovigilance World 2026 Conference
  
  Reports
  Session “EAEU’s common market of medicinal products for veterinary use” at the All-Russian GMP Conference 2025
  
  Reports
  Moscow Hosts the X GMP Conference Under the Motto “Regulating Today — Creating a Stable Tomorrow”
  
  Reports
  Pharmtech & Ingredients International Exposition 2022 Results
Companies
Glossary

Hot topics

Manufacturing
Regulatory
AI in Pharma
Expert Opinion
Global Markets

Instagram

Twitter

Manufacturing

Production of the Russian Smallpox Drug “NIOCH-14” May Start in the Spring of 2026

This is the first chemical drug in Russia intended for the treatment and emergency prevention of smallpox and other orthopoxvirus infections, including mpox.

R-Pharm Import-Substitutes German Erbitux — Drug for Head and Neck Cancer Therapy

The Ministry of Health of the Russian Federation has...

Petrovax Pharm Investments in Meningitis Vaccine Production Exceed 3 Billion Rubles

Biopharmaceutical company Petrovax Pharm has announced receiving an expanded...

00:00:22

Ellara Prepares to Launch Unique Peptide Synthesis Facility

Pharmaceutical company Ellara is completing preparations for the opening...

GMP Registry: New Certificates Issued and Refusals in January 2026

On January 26, the Ministry of Industry and Trade...

Global Markets

CapVest Closes Deal to Acquire Controlling Stake in STADA

International investment firm CapVest Partners has officially announced the...

Eli Lilly to Acquire Centessa Pharmaceuticals for $7.8 Billion to Advance Sleep Disorders Portfolio

Pharmaceutical corporation Eli Lilly has announced a definitive agreement...

EMA Publishes GMDP Inspectors Work Plan for 2026–2028: Focus on AI, Supply Chain Protection, and Global Partnership

The European Medicines Agency (EMA) has presented the three-year...

Top 10 Big Pharma Companies by R&D Spending in 2025 Published

The past year, 2025, proved to be a period...

American Scientists Create an Implant That Autonomously Produces Drugs Inside the Body

An inter-institutional team of researchers led by Northwestern University,...

Politics

Russia Approves First National Standard for 3D Bioprinting of Tissues and Organs

Russia has officially adopted the first national standard regulating...

Published Amendments to the EAEU Veterinary Drugs Circulation Rules: The Transition Period has been Extended until 2030

On March 25, the text of EEC Council Decision...

Rosselkhoznadzor has received authority to issue veterinary EAEU GMP certificates

In Russia, the legal framework for issuing EAEU GMP...

Rospotrebnadzor Cleans Up the Web: 3,000 Resources with Dangerous Dietary Supplements Blocked

The Federal Service for Surveillance on Consumer Rights Protection...

Automated Fines for Expired Dietary Supplements to Start March 1 for Pharmacies

The dietary supplement (BAA) market will be the first...

AI in Pharma

AI and Billion-Dollar Investments: Eli Lilly Signs an Agreement with Insilico Medicine Worth Up to $2.75 Billion

American pharmaceutical giant Eli Lilly continues to actively invest in artificial intelligence technologies and biotechnological developments.

Eli Lilly and Nvidia Launch LillyPod — The Most Powerful AI Supercomputer in Global Pharma

On February 25, 2026, pharmaceutical giant Eli Lilly officially...

An “AI Pill” for Indian Pharma: Sun Pharma and Glenmark Change the Rules of the Game

The Indian pharmaceutical industry, long known as the "pharmacy of the world" due to its generic drug production, is beginning a technological transformation.

SUSU Scientists Synthesize a Selective Anti-Anxiety Molecule

Researchers at South Ural State University (SUSU) have discovered...

Neural Network Breakthrough: FDA Approves Trials for AI-Created Parkinson’s Drug

January 23, 2026, became a landmark date for digital...

News
- All EAEU Market Education Global Markets Manufacturing
  
  News
  Russian-Chinese Blood Plasma Production to be Localized in Nizhny Novgorod Region
  
  News
  Biotechnology Company BIOCAD Launches Its Own Biobank
  
  News
  GMP Registry Update: 16 New Certificates at the Turn of March and April 2026
  
  News
  VGNKI Inspects Four Foreign Veterinary Drug Manufacturers Since Early 2026
Insights
- All Expert Opinion Partner Posts
  
  Insights
  Russian Pharmaceutical Market in 2025: Production Growth and Import Substitution Course
  
  Expert Opinion
  GMP Registry Update: 8 New Certificates by the End of February 2026
  
  Expert Opinion
  Vadim Kukava: The Pharmaceutical Industry Should Not Be Divided into “Theirs” and “Ours”
  
  Global Markets
  Top Ten Most Anticipated Drug Launches of 2026 That Will Reshape the Global Market
Innovation
- All AI in Pharma Approvals Drug Development Research
  
  News
  New Equilibrium: Analytical Review of the Clinical Trials Market in Russia for 2025
  
  Drug Development
  American Scientists Create an Implant That Autonomously Produces Drugs Inside the Body
  
  AI in Pharma
  AI and Billion-Dollar Investments: Eli Lilly Signs an Agreement with Insilico Medicine Worth Up to $2.75 Billion
  
  Research
  New Horizons in SMA Treatment: Promomed Launches Large-Scale Study Based on Risdiplam
Events
- All Reports Upcoming
  
  Upcoming
  PHARMPROM Portal Becomes a Media Partner of the International Pharmacovigilance World 2026 Conference
  
  Reports
  Session “EAEU’s common market of medicinal products for veterinary use” at the All-Russian GMP Conference 2025
  
  Reports
  Moscow Hosts the X GMP Conference Under the Motto “Regulating Today — Creating a Stable Tomorrow”
  
  Reports
  Pharmtech & Ingredients International Exposition 2022 Results
Companies
Glossary

Hot topics

Manufacturing
Regulatory
AI in Pharma
Expert Opinion
Global Markets

Instagram

Twitter

Manufacturing

Production of the Russian Smallpox Drug “NIOCH-14” May Start in the Spring of 2026

This is the first chemical drug in Russia intended for the treatment and emergency prevention of smallpox and other orthopoxvirus infections, including mpox.

R-Pharm Import-Substitutes German Erbitux — Drug for Head and Neck Cancer Therapy

The Ministry of Health of the Russian Federation has...

Petrovax Pharm Investments in Meningitis Vaccine Production Exceed 3 Billion Rubles

Biopharmaceutical company Petrovax Pharm has announced receiving an expanded...

00:00:22

Ellara Prepares to Launch Unique Peptide Synthesis Facility

Pharmaceutical company Ellara is completing preparations for the opening...

GMP Registry: New Certificates Issued and Refusals in January 2026

On January 26, the Ministry of Industry and Trade...

Global Markets

CapVest Closes Deal to Acquire Controlling Stake in STADA

International investment firm CapVest Partners has officially announced the...

Eli Lilly to Acquire Centessa Pharmaceuticals for $7.8 Billion to Advance Sleep Disorders Portfolio

Pharmaceutical corporation Eli Lilly has announced a definitive agreement...

EMA Publishes GMDP Inspectors Work Plan for 2026–2028: Focus on AI, Supply Chain Protection, and Global Partnership

The European Medicines Agency (EMA) has presented the three-year...

Top 10 Big Pharma Companies by R&D Spending in 2025 Published

The past year, 2025, proved to be a period...

American Scientists Create an Implant That Autonomously Produces Drugs Inside the Body

An inter-institutional team of researchers led by Northwestern University,...

Politics

Russia Approves First National Standard for 3D Bioprinting of Tissues and Organs

Russia has officially adopted the first national standard regulating...

Published Amendments to the EAEU Veterinary Drugs Circulation Rules: The Transition Period has been Extended until 2030

On March 25, the text of EEC Council Decision...

Rosselkhoznadzor has received authority to issue veterinary EAEU GMP certificates

In Russia, the legal framework for issuing EAEU GMP...

Rospotrebnadzor Cleans Up the Web: 3,000 Resources with Dangerous Dietary Supplements Blocked

The Federal Service for Surveillance on Consumer Rights Protection...

Automated Fines for Expired Dietary Supplements to Start March 1 for Pharmacies

The dietary supplement (BAA) market will be the first...

AI in Pharma

AI and Billion-Dollar Investments: Eli Lilly Signs an Agreement with Insilico Medicine Worth Up to $2.75 Billion

American pharmaceutical giant Eli Lilly continues to actively invest in artificial intelligence technologies and biotechnological developments.

Eli Lilly and Nvidia Launch LillyPod — The Most Powerful AI Supercomputer in Global Pharma

On February 25, 2026, pharmaceutical giant Eli Lilly officially...

An “AI Pill” for Indian Pharma: Sun Pharma and Glenmark Change the Rules of the Game

The Indian pharmaceutical industry, long known as the "pharmacy of the world" due to its generic drug production, is beginning a technological transformation.

SUSU Scientists Synthesize a Selective Anti-Anxiety Molecule

Researchers at South Ural State University (SUSU) have discovered...

Neural Network Breakthrough: FDA Approves Trials for AI-Created Parkinson’s Drug

January 23, 2026, became a landmark date for digital...

About us
GMP Database
Services
Promotion
Contact
? RU

PHARMPROM is a premier digital resource for the pharmaceutical sector, combining breaking news, deep insights, and key market events. We cover the entire product lifecycle—from R&D and manufacturing to distribution—in strict accordance with Good Pharmaceutical Practices (GxP).

Disclaimer All content on pharmprom.net is for informational purposes only and does not constitute medical advice. The materials are intended exclusively for industry professionals and are not addressed to the general public.

Company

News
Insights
Innovation
Events
Companies
Glossary

I've read and accept the Privacy Policy.

Flipboard

Tumblr

About us
GMP Database
Services
Promotion
Contact
? RU

Company

News
Insights
Innovation
Events
Companies
Glossary

I've read and accept the Privacy Policy.

Flipboard

Tumblr

Hot topics

Manufacturing

Global Markets

Politics

AI in Pharma

Hot topics

Manufacturing

Global Markets

Politics

AI in Pharma

Company

Headlines

Newsletter

Company

Headlines

Newsletter